After photos of Donald Trump with swollen ankles sparked health fears, a physician has raised concerns that the President may be facing a serious health issue.

The drug is now approved for treating people with an LVEF of at least 40%, with or without chronic kidney disease.

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

Following priority review, the FDA approved Kerendia for the treatment of patients with heart failure with left ventricular ejection fraction (LVEF) ≥40%.

Dr Jen Caudle has revealed the 'most common' symptoms of heart failure which her patients typically present with, to help ...

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

Heart failure occurs when the heart muscle does not pump blood as well as it should. Heart failure symptoms can sometimes be ...

When people think of heart problems, they often imagine chest pain or trouble breathing. But not many know that a constant ...

SGLT2 inhibitors reduced heart failure events and cardiovascular death in patients with heart failure, type 2 diabetes, chronic kidney disease, and atherosclerotic cardiovascular disease. These ...

Doctors were able to resuscitate him. Then, they got to work trying to figure out what was wrong. The man told them that for ...

If you’ve been brushing off persistent fatigue frequent headaches or unexplained weight changes your body might be telling ...

Mounting research links chronic inflammation to nearly every modern chronic disease — from heart disease and diabetes to ...